Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Over six cups of coffee a day may reduce the risk of developing multiple sclerosis.
Motor programme activating therapy influences adaptive brain functions in multiple sclerosis: clinical and MRI study.
Role of statins in the treatment of multiple sclerosis.
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in sweden.
Assessing walking disability in multiple sclerosis.
Transcriptional enhancers: from properties to genome-wide predictions.
Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain.
TAPP1 inhibits the differentiation of oligodendrocyte precursor cells via suppressing the Mek/Erk pathway.
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.
Preclinical retinal neurodegeneration in a model of multiple sclerosis.
Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial.
Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging.
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients.
Association of multiple sclerosis susceptibility variants and early attack location in the CNS.
Eosinophilic Fasciitis Occurring under Treatment with Natalizumab for Multiple Sclerosis.
Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis.
miR-15a and 16-1 are downregulated in CD4(+) T cells of multiple sclerosis relapsing patients.
Interpretation and visualization of non-linear data fusion in kernel space: study on metabolomic characterization of progression of multiple sclerosis.
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.
Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
Physiotherapy as an immunoactive therapy? A pilot study.
Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, th17- and activated B-cells and correlates with progression.
Pages
« first
‹ previous
…
169
170
171
172
173
174
175
176
177
…
next ›
last »